TABLE 2

Seizure Severity and Risk Estimates for Each Severity Indicator, Comparing VP-FS and NVP-FS Cases

All (n = 1022)NVP-FS (n = 955)VP-FS (n = 67)UnivariateMultivariate
n (%)n (%) n (%)OR (95% CI)PaORa (95% CI)P
Admission details
 LOS >1 d126 (12.3)114 (11.9)12 (17.9)1.61 (0.84–3.10).151.50 (0.76–2.94).24
 Transfer from peripheral hospital61 (6.0)52 (5.4)9 (13.4)2.70 (1.27–5.74).012.36 (1.09–5.11).03
 ICU admission20 (2.0)19 (2.0)1 (1.5)0.72 (0.10–5.48).750.67 (0.09–5.16).70
 Death1 (0.1)1 (0.1)0 (0.0)NC
Seizure details
 Seizure duration >15 min108 (10.6)98 (10.3)10 (14.9)1.47 (0.73–2.98).281.40 (0.70–2.79).34
 Repeat seizures 24 h after presentation96 (9.4)90 (9.4)6 (9.0)0.80 (0.34–1.89).610.88 (0.59–1.31).44
AED use
 AED for termination of seizure80 (7.8)70 (7.3)10 (14.9)2.22 (1.09–4.53).032.24 (1.07–4.67).03
 AED on discharge18 (1.8)6 (1.7)2 (3.0)1.81 (0.41–8.02).441.68 (0.37–7.66).50
Follow-up details
 Readmission within 48 h with FS8 (0.8)8 (0.8)0 (0.0)NC
 FS recurrenceb at 6 mo88 of 398 (22.1)81 of 373 (21.7)7 of 25 (28.0%)1.40 (0.57–3.47).471.17 (0.46–2.94).75
  • NC, not calculated; OR, odds ratio; —, not applicable.

  • a Multivariate analysis adjusted for age group (<12, 12–24, 24–36, ≥36 mo) and sex.

  • b Subset of 398 patients who were followed-up 6 mo after initial FS.